• Evaluation of the therapeutic and prophylactic potential of the drug Canephron® N in the treatment of gestational pyelonephritis in pregnant women

Evaluation of the therapeutic and prophylactic potential of the drug Canephron® N in the treatment of gestational pyelonephritis in pregnant women

HEALTH OF WOMAN. 2018.5(132):62–66; doi 10.15574/HW.2018.132.62

Sheremeta R. Z., Sabadash M. E., Shulyak O. V.
Lviv Regional Clinical Hospital
SI Institute of Urology NAMS of Ukraine, Kyiv

Gestational pyelonephritis (GP) is one of the most frequent and serious diseases of the middle and second half of pregnancy, which complicates about 6% of pregnancies and is one of the leading causes of non-obstetric prenatal hospitalization.

The objective: was to improve the treatment of GP with phytopreparation Canephron® N.

Materials and methods. The paper provides data from the open, multicentre, prospective, comparative (parallel group) study in 60 pregnant women diagnosed with gestational pyelonephritis, which were divided into two groups 30 subjects each. Patients in the treatment group received antibacterial therapy for 7 days + treatment with standard dosage of medicinal product Canephron® N for 3 months. Patients in the control group received antibiotic therapy alone for 7 days.

Results. The average age of pregnant women at the time of diagnosing was 23±6.23 years; it was the first pregnancy for 39 women (65 %). The most common complaints at admission to the in-patient department were as follows: lumbar pain (96.2 %), dysuria (70.2 %), rise in temperature above 38°C (64.4 %). Leukocyturia and bacteriuria were detected in 100 % of cases with prevalence of E. coli in 84.2 % (101 of 120) of cases. By 30 day in GP patients in the treatment group bacteriuria was detected in 2/30 (6.67 %) patients, and in the control group – in 5/30 (16.7 %) patients (p 1: 2 <0.05), by 60 day in the treatment group – 2/30 (6.67 %), in the control group – 8/30 (26.7 %) (p 1: 2 <0.05), respectively, by 90 day – 3/30 (10 %) and 10 (33.3 %), respectively (p 1: 2 <0.05). The disease relapsed in 1 of 30 (3.33 %) GP patients in the treatment group and 3/30 (10 %) patients in the control group (p 1: 2 <0.05) and 3/30 (10 %) patients in the treatment group with CP, and 7/30 (23.3 %) patients in the control group during the follow-up period (p 1: 2 <0.05).

Conclusion. The use of the herbal medicinal product Canephron® N in pregnant women with gestational pyelonephritis and in the acute exacerbations of chronic pyelonephritis has shown its high efficacy and undoubted therapeutic and prophylactic effect, good tolerability and decrease in the frequency of relapses of pyelonephritis.

Key words: gestational pyelonephritis, pregnancy, Canephron® N, leukocyturia, bacteriuria, urosepsis, kidney, infection, urinary tract.


1. Aylamazyan EK, Kulakov VI, Radzinskiy VE, Saveleva GM. 2009. Akusherstvo. Natsionalnoe rukovodstvo. M, «GEOTAR-Media»:1200.

2. Kulakova VI, Serov VN. 2006. Lekarstvennyie sredstva, primenyaemyie v akusherstve i ginekologii. 2-e izdanie. M, «GEOTAR-Media»:384.

3. Safronova LA. 2000. Pielonefrit i beremennost. Russkiy meditsinskiy zhurnal 8;18:778–781.

4. Sidelnikova VM, Antonov AG. 2006. Prezhdevremennyie rodyi. Nedonoshennyiy rebenok. M, «GEOTAR-Media»:448.

5. Shihovtseva SV, Merkulova LM. 2006, sent. 26–27. Dopplerograficheskoe issledovanie pochechnogo krovotoka pri diffuznoy patologii pochek. Materialyi IX simpoziuma s mezhdunarodnyim uchastiem «Novyie diagnosticheskie tehnologii v luchevoy diagnostike». M.

6. Dalal S, Nicolle L, Marrs CF, Zhang L, Harding G, Foxman B. 2009. Long-term Escherichia coli asymptomatic bacteriuria among women with diabetes mellitus. Clinical Infectious Diseases. 49(4):491–497. https://doi.org/10.1086/600883; PMid:19583518 PMCid:PMC2833278

7. Geerlings SE. 2008. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. International Journal of Antimicrobial Agents 31(1):54–57. https://doi.org/10.1016/j.ijantimicag.2007.07.042; PMid:18054467

8. Gilstrap LC, Cunningham FG, Whalley PJ. 1981. Acute pyelonephritis in pregnancy: an anterospective study. Obstetrics and Gynecology 57(4):409–413. PMid:7243084

9. Gilstrap LC, Ramin SM. 2001. Urinary tract infections during pregnancy. Obstetrics and Gynecology Clinics of North America 8(3):581–591. https://doi.org/10.1016/S0889-8545(05)70219-9

10. Hanchard NA, Hambleton I, Harding CA, McKenzie RM. 2005. The frequency of the sickle allele in Jamaica has not declined over the last 22 years. British Journal of Haematology 130(6):939–942. https://doi.org/10.1111/j.1365-2141.2005.05704.x; PMid:16156863

11. Hill JB, Sheffield JS, McIntire DD, Wendel GD. 2005. Acute pyelonephritis in pregnancy. Obstetrics and Gynecology 105(1):18–23. https://doi.org/10.1097/01.AOG.0000149154.96285.a0; PMid:15625136

12. Kokrdová Z, Pařízek A, Koucký M, Pašková A, Boudová B. 2016, Summer. Septic shock in pregnancy on the basis of an acute pyelonephritis. Ceska Gynekol. 81(4):286-288. Czech. PMid:27882751

13. Kumar S, Dave A, Wolf B, Lerma EV. 2015, Feb. Urinary tract infections. Dis Mon. 61(2):45-59. https://doi.org/10.1016/j.disamonth.2014.12.002. Review. No abstract available.

14. Oktar SO et al. 2004, Jul. Doppler sonography of renal obstruction: value of venoue impedance index measurements. J Ultrasound Med. 23(7). https://doi.org/10.7863/jum.2004.23.7.929

15. Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. 2015,  Mar 16.  Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci. 11(1):67-77. https://doi.org/10.5114/aoms.2013.39202.

16. Patterson TF, Andriole VT. 1997. Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infectious Disease Clinics of North America 11(3):593–608. https://doi.org/10.1016/S0891-5520(05)70375-5

17. Pazos Otero N, Fuentes Ricoy L, Ferrández Pérez B, Martínez Vázquez C, Martínez Poch M, Osuna Díaz JL. 2007. Pyelonephritis and pregnancy. Our experience in a general hospital. Anales de Medicina Interna. 24(12):585–587. PMid:18278996

18. Sheiner E, Mazor-Drey E, Levy A. 2009. Asymptomatic bacteriuria during pregnancy. Journal of Maternal-Fetal and Neonatal Medicine 22(5):423–427. https://doi.org/10.1080/14767050802360783; PMid:19530000

19. Smaill FM, Vazquez JC. 2015, Aug 7. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. (8):CD000490. https://doi.org/10.1002/14651858.CD000490.pub3. Review.